Leave Your Message
ADT1564-Rovelizumab Biosimilar-(ITGAL/CD11a/ITGB2/CD18)-Research Biosimilar Antibody
Antibody

ADT1564-Rovelizumab Biosimilar-(ITGAL/CD11a/ITGB2/CD18)-Research Biosimilar Antibody

  • Catalog Number ADT1564
  • Host CHO Cells
  • Species Human
  • Target ITGAL/CD11a/ITGB2/CD18
  • Application ELISA, WB

With Alpha Lifetech, you can order biosimilar antibodies when needed. We offer a flexible ordering system that allows you to place orders according to project schedules. Our efficient manufacturing and strict processes ensure timely delivery, ensuring that you can research or produce according to plan.

Products Categories
Featured Products
recommended service
quick links
Contact Us

Product Background

ITGAL (Integrin Alpha L), also known as CD11a, pairs with CD18 (ITGB2) to form the heterodimeric integrin LFA-1 (Lymphocyte Function-Associated Antigen 1). Structurally, ITGAL contains a large extracellular domain with a β-propeller region for ligand binding (e.g., ICAM-1, ICAM-2), a transmembrane helix, and a cytoplasmic tail that facilitates intracellular signaling.

Product Specification

Catalog Number

ADT1564

Product Name

ADT1564-Rovelizumab Biosimilar-(ITGAL/CD11a/ITGB2/CD18)-Research Biosimilar Antibody

Clonity

Monoclonal

Alternate Names

anti-mouse ITGAL antibody,  anti-ITGAL antibody,  anti ITGAL antibody,  recombinant ITGAL,  ITGAL antibody,  anti-ITGAL monoclonal antibody,  ITGAL antibodies,  ITGAL recombinant antibody,  ITGAL blocking antibody,  CD11a recombinant antibody,  CD11a blocking antibody,  ITGB2 recombinant antibody,  ITGB2 blocking antibody,  CD18 recombinant antibody,  CD18 blocking antibody

Alias

Hu23F2G

Host

CHO Cells

Species

Human

Target

ITGAL/CD11a/ITGB2/CD18

Gene ID

3683

Isotype

IgG4

Size

1mg, 5mg

Research Area

Immunology

CAS Number

339086-79-2

Product Description

Rovelizumab,  also known as LeukArrest and Hu23F2G,  is a humanized monoclonal antibody which was an experimental immunosuppressive drug. Rovelizumab was developed by Icos to treat patients suffering from haemorrhagic shock. The drug is a monoclonal antibody that suppresses white blood cells which become overly active during shock.

Application

ELISA,  WB

Purity

>95% as determined by SDS-PAGE

Concentration

batch dependent

Buffer

Supplied in PBS,  PH7.5

Storage

Store at -20 °C for 12 months. Store at -80 °C for long term storage.

Shipping Condition

Shipped on ice packs.

Note

This product is for research use only.

Reference

1. Hickman A,  et al. J Clin Invest,  2022 Jul 1. PMID 35552271
2. Liu YX,  et al. Int J Clin Exp Pathol,  2015. PMID 26884833
3. Chigaev A,  et al. Mol Biol Cell,  2015 Jan 1. PMID 25378583